CA Stock MarketDetailed Quotes

AGN Algernon Pharmaceuticals Inc

Watchlist
  • 0.075
  • +0.005+7.14%
15min DelayMarket Closed Dec 13 15:59 ET
2.05MMarket Cap-2.21P/E (TTM)

Algernon Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
(Q1)Nov 30, 2022
(FY)Aug 31, 2022
(Q4)Aug 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-143.65%-1.79M
45.70%-239.05K
93.53%-52.24K
12.35%-2.55M
61.08%-572.71K
21.18%-732.94K
48.22%-440.22K
-338.14%-807.14K
62.77%-2.91M
-80.72%-1.47M
Net income from continuing operations
228.09%1.44M
19.53%-1M
72.26%-521.55K
-12.01%-6.78M
-13.95%-2.53M
-40.80%-1.13M
32.05%-1.25M
-56.60%-1.88M
21.72%-6.05M
-822.80%-2.22M
Operating gains losses
-14,511.01%-1.91M
-129.18%-6.41K
-56.82%10.82K
263.89%73.95K
162.81%13.65K
35,770.27%13.27K
255.08%21.97K
370.68%25.05K
-248.48%-45.12K
77.21%-21.73K
Depreciation and amortization
-52.58%6.09K
-39.04%7.64K
-36.46%7.43K
44.26%50.4K
-53.00%13.34K
552.70%12.83K
173.23%12.54K
--11.69K
--34.94K
--28.38K
Asset impairment expenditure
----
----
----
4,125.19%1.54M
----
----
----
----
--36.48K
----
Remuneration paid in stock
-68.57%61.01K
-60.46%156.61K
-88.43%69.04K
136.76%1.26M
-69.50%69.8K
1,256.22%194.1K
37.70%396.12K
--596.8K
-35.84%530.84K
298.69%228.86K
Other non cashItems
----
----
----
--40K
----
----
----
----
----
----
Change In working capital
-894.81%-1.38M
61.17%607.01K
-13.05%382.03K
-51.03%1.27M
-41.81%275.59K
219.59%174.15K
-46.79%376.64K
-71.63%439.34K
532.28%2.58M
305.05%473.58K
-Change in receivables
17.94%21.92K
-113.79%-16.69K
-81.98%81.72K
-64.83%567.8K
84.60%-25.22K
151.42%18.58K
178.94%121.01K
-76.96%453.43K
240.31%1.61M
-139.81%-163.71K
-Change in prepaid assets
-163.42%-52.34K
-93.21%17.31K
-74.43%85.45K
215.37%634.37K
93.55%-37.24K
1,582.20%82.53K
377.09%254.93K
1,737.27%334.15K
-398.61%-549.84K
-358.31%-577.3K
-Change in payables and accrued expense
-1,953.40%-1.35M
86,280.48%606.39K
153.44%186.11K
-95.82%63.54K
-72.17%338.05K
170.28%73.04K
-99.91%702
12.60%-348.25K
312.28%1.52M
240.30%1.21M
-Change in other working capital
--0
--0
--28.75K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-143.65%-1.79M
45.70%-239.05K
93.53%-52.24K
12.35%-2.55M
61.08%-572.71K
21.18%-732.94K
48.22%-440.22K
-338.14%-807.14K
62.77%-2.91M
-80.72%-1.47M
Investing cash flow
Cash flow from continuing investing activities
8,640.70%2.31M
-152.13%-23.12K
0
58.85%-59.5K
88.63%-5.58K
-151.17%-27.01K
79.50%-9.17K
55.71%-17.74K
-16.20%-144.61K
-372.51%-49.07K
Net intangibles purchas and sale
10,038.86%2.68M
-152.13%-23.12K
--0
58.85%-59.5K
88.63%-5.58K
-151.17%-27.01K
79.50%-9.17K
55.71%-17.74K
-16.20%-144.61K
-372.51%-49.07K
Cash from discontinued investing activities
Investing cash flow
8,640.70%2.31M
-152.13%-23.12K
--0
58.85%-59.5K
88.63%-5.58K
-151.17%-27.01K
79.50%-9.17K
55.71%-17.74K
-16.20%-144.61K
-372.51%-49.07K
Financing cash flow
Cash flow from continuing financing activities
-99.23%7.5K
1,645.46%265.57K
0
-35.34%1.33M
-86.90%269.17K
974K
-17.18K
102.93K
-51.59%2.06M
3,725.00%2.06M
Net common stock issuance
--0
----
----
-40.35%1.23M
-91.86%167.25K
--1.05M
----
----
-23.70%2.06M
5,037.81%2.06M
Proceeds from stock option exercised by employees
--7.5K
--0
--0
--102.93K
--0
--0
--0
--102.93K
--0
--0
Net other financing activities
----
----
----
----
----
---80.2K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-99.23%7.5K
1,645.46%265.57K
--0
-35.34%1.33M
-86.90%269.17K
--974K
---17.18K
--102.93K
-51.59%2.06M
3,725.00%2.06M
Net cash flow
Beginning cash position
-65.42%76.28K
-89.25%74.17K
-91.12%125.09K
-41.58%1.41M
-50.25%434.23K
-87.84%220.59K
-74.43%689.7K
-41.58%1.41M
-60.61%2.41M
-73.45%872.84K
Current changes in cash
147.05%528.8K
100.73%3.41K
92.76%-52.24K
-28.07%-1.28M
-157.84%-309.12K
122.75%214.05K
47.86%-466.58K
-341.55%-721.95K
72.93%-1M
160.64%534.44K
Effect of exchange rate changes
1,218.09%4.45K
48.88%-1.3K
-57.75%1.33K
140.89%175
-102.12%-26
-278.48%-398
-122.83%-2.54K
124.14%3.14K
94.91%-428
-73.04%1.23K
End cash Position
40.37%609.52K
-65.42%76.28K
-89.25%74.17K
-91.12%125.09K
-91.12%125.09K
-50.25%434.23K
-87.84%220.59K
-74.43%689.7K
-41.58%1.41M
-41.58%1.41M
Free cash from
-138.89%-1.82M
41.66%-262.17K
93.67%-52.24K
14.55%-2.61M
61.97%-578.29K
19.21%-759.95K
49.78%-449.39K
-375.99%-824.88K
61.53%-3.06M
-84.39%-1.52M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)May 31, 2024(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023(Q1)Nov 30, 2022(FY)Aug 31, 2022(Q4)Aug 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -143.65%-1.79M45.70%-239.05K93.53%-52.24K12.35%-2.55M61.08%-572.71K21.18%-732.94K48.22%-440.22K-338.14%-807.14K62.77%-2.91M-80.72%-1.47M
Net income from continuing operations 228.09%1.44M19.53%-1M72.26%-521.55K-12.01%-6.78M-13.95%-2.53M-40.80%-1.13M32.05%-1.25M-56.60%-1.88M21.72%-6.05M-822.80%-2.22M
Operating gains losses -14,511.01%-1.91M-129.18%-6.41K-56.82%10.82K263.89%73.95K162.81%13.65K35,770.27%13.27K255.08%21.97K370.68%25.05K-248.48%-45.12K77.21%-21.73K
Depreciation and amortization -52.58%6.09K-39.04%7.64K-36.46%7.43K44.26%50.4K-53.00%13.34K552.70%12.83K173.23%12.54K--11.69K--34.94K--28.38K
Asset impairment expenditure ------------4,125.19%1.54M------------------36.48K----
Remuneration paid in stock -68.57%61.01K-60.46%156.61K-88.43%69.04K136.76%1.26M-69.50%69.8K1,256.22%194.1K37.70%396.12K--596.8K-35.84%530.84K298.69%228.86K
Other non cashItems --------------40K------------------------
Change In working capital -894.81%-1.38M61.17%607.01K-13.05%382.03K-51.03%1.27M-41.81%275.59K219.59%174.15K-46.79%376.64K-71.63%439.34K532.28%2.58M305.05%473.58K
-Change in receivables 17.94%21.92K-113.79%-16.69K-81.98%81.72K-64.83%567.8K84.60%-25.22K151.42%18.58K178.94%121.01K-76.96%453.43K240.31%1.61M-139.81%-163.71K
-Change in prepaid assets -163.42%-52.34K-93.21%17.31K-74.43%85.45K215.37%634.37K93.55%-37.24K1,582.20%82.53K377.09%254.93K1,737.27%334.15K-398.61%-549.84K-358.31%-577.3K
-Change in payables and accrued expense -1,953.40%-1.35M86,280.48%606.39K153.44%186.11K-95.82%63.54K-72.17%338.05K170.28%73.04K-99.91%70212.60%-348.25K312.28%1.52M240.30%1.21M
-Change in other working capital --0--0--28.75K----------------------------
Cash from discontinued investing activities
Operating cash flow -143.65%-1.79M45.70%-239.05K93.53%-52.24K12.35%-2.55M61.08%-572.71K21.18%-732.94K48.22%-440.22K-338.14%-807.14K62.77%-2.91M-80.72%-1.47M
Investing cash flow
Cash flow from continuing investing activities 8,640.70%2.31M-152.13%-23.12K058.85%-59.5K88.63%-5.58K-151.17%-27.01K79.50%-9.17K55.71%-17.74K-16.20%-144.61K-372.51%-49.07K
Net intangibles purchas and sale 10,038.86%2.68M-152.13%-23.12K--058.85%-59.5K88.63%-5.58K-151.17%-27.01K79.50%-9.17K55.71%-17.74K-16.20%-144.61K-372.51%-49.07K
Cash from discontinued investing activities
Investing cash flow 8,640.70%2.31M-152.13%-23.12K--058.85%-59.5K88.63%-5.58K-151.17%-27.01K79.50%-9.17K55.71%-17.74K-16.20%-144.61K-372.51%-49.07K
Financing cash flow
Cash flow from continuing financing activities -99.23%7.5K1,645.46%265.57K0-35.34%1.33M-86.90%269.17K974K-17.18K102.93K-51.59%2.06M3,725.00%2.06M
Net common stock issuance --0---------40.35%1.23M-91.86%167.25K--1.05M---------23.70%2.06M5,037.81%2.06M
Proceeds from stock option exercised by employees --7.5K--0--0--102.93K--0--0--0--102.93K--0--0
Net other financing activities -----------------------80.2K----------------
Cash from discontinued financing activities
Financing cash flow -99.23%7.5K1,645.46%265.57K--0-35.34%1.33M-86.90%269.17K--974K---17.18K--102.93K-51.59%2.06M3,725.00%2.06M
Net cash flow
Beginning cash position -65.42%76.28K-89.25%74.17K-91.12%125.09K-41.58%1.41M-50.25%434.23K-87.84%220.59K-74.43%689.7K-41.58%1.41M-60.61%2.41M-73.45%872.84K
Current changes in cash 147.05%528.8K100.73%3.41K92.76%-52.24K-28.07%-1.28M-157.84%-309.12K122.75%214.05K47.86%-466.58K-341.55%-721.95K72.93%-1M160.64%534.44K
Effect of exchange rate changes 1,218.09%4.45K48.88%-1.3K-57.75%1.33K140.89%175-102.12%-26-278.48%-398-122.83%-2.54K124.14%3.14K94.91%-428-73.04%1.23K
End cash Position 40.37%609.52K-65.42%76.28K-89.25%74.17K-91.12%125.09K-91.12%125.09K-50.25%434.23K-87.84%220.59K-74.43%689.7K-41.58%1.41M-41.58%1.41M
Free cash from -138.89%-1.82M41.66%-262.17K93.67%-52.24K14.55%-2.61M61.97%-578.29K19.21%-759.95K49.78%-449.39K-375.99%-824.88K61.53%-3.06M-84.39%-1.52M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data